Wealth Alliance Gilead Sciences, Inc. Transaction History

Wealth Alliance

$818 Million
Q3 2024

A detailed history of Wealth Alliance transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wealth Alliance holds 20,792 shares of GILD stock, worth $1.95 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

20,792

Previous 19,905 4.46%

Holding current value

$1.95 Million

Previous $1.37 Million 27.62%

% of portfolio

0.21%

Previous 0.18%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$66.59 - $83.99 $59,065 - $74,499	887 Added 4.46%	20,792 $1.74 Million
Q2 2024 Aug 09, 2024	BUY	$63.15 - $72.88 $360,965 - $416,582	5,716 Added 40.28%	19,905 $1.37 Million
Q1 2024 May 10, 2024	BUY	$71.58 - $87.29 $179,093 - $218,399	2,502 Added 21.41%	14,189 $1.04 Million
Q4 2023 Jan 30, 2024	BUY	$73.27 - $83.09 $29,014 - $32,903	396 Added 3.51%	11,687 $946,000
Q3 2023 Nov 09, 2023	BUY	$73.94 - $80.67 $76,749 - $83,735	1,038 Added 10.12%	11,291 $846,000
Q2 2023 Aug 02, 2023	SELL	$76.01 - $86.7 $214,196 - $244,320	-2,818 Reduced 21.56%	10,253 $790,000
Q1 2023 May 10, 2023	SELL	$77.31 - $88.08 $578,356 - $658,926	-7,481 Reduced 36.4%	13,071 $1.08 Million
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $202,166 - $290,240	-3,244 Reduced 13.63%	20,552 $1.76 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $21,374 - $24,415	359 Added 1.53%	23,796 $1.47 Million
Q2 2022 Oct 11, 2022	BUY	$57.72 - $65.01 $185,742 - $209,202	3,218 Added 15.92%	23,437 $1.45 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $139,740 - $157,389	2,421 Added 13.6%	20,219 $1.25 Million
Q1 2022 May 10, 2022	BUY	$57.92 - $72.58 $113,928 - $142,764	1,967 Added 12.42%	17,798 $1.06 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $2,465 - $2,798	-38 Reduced 0.24%	15,831 $1.15 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $28,903 - $31,183	427 Added 2.77%	15,869 $1.11 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $92,158 - $100,696	1,452 Added 10.38%	15,442 $1.06 Million
Q1 2021 May 18, 2021	BUY	$60.0 - $68.46 $42,420 - $48,401	707 Added 5.32%	13,990 $904,000
Q4 2020 Feb 11, 2021	BUY	$56.65 - $64.55 $144,344 - $164,473	2,548 Added 23.74%	13,283 $773,000
Q3 2020 Nov 13, 2020	BUY	$62.1 - $78.08 $375,705 - $472,384	6,050 Added 129.14%	10,735 $678,000
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $492,273 - $571,620	-6,805 Reduced 59.23%	4,685 $360,000
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $14,905 - $19,092	238 Added 2.12%	11,490 $859,000
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $648,304 - $713,113	10,521 Added 1439.26%	11,252 $731,000
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $45,044 - $49,547	731 New	731 $731,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Alliance, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Alliance with notifications on news.

Account